• JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
 
  Bookmark and Share
 
 
Doctoral Thesis
DOI
https://doi.org/10.11606/T.5.2006.tde-22032006-102746
Document
Author
Full name
Evaldo Stanislau Affonso de Araújo
Institute/School/College
Knowledge Area
Date of Defense
Published
São Paulo, 2005
Supervisor
Committee
Barone, Antonio Alci (President)
Carrilho, Flair José
Ferraz, Maria Lúcia Cardoso Gomes
Mello, Carlos Eduardo Brandão
Nita, Suzane Kioko Ono
 
Title in Portuguese
"Estudo da cinética viral do vírus da hepatite C em pacientes co-infecatados com o HIV"
Keywords in Portuguese
Cinética
Hepatite C
HIV
Interferon alfa-2a
Abstract in Portuguese
Vinte e seis pacientes portadores de Hepatite C crônica e co-infectados pelo HIV, sem outras causas para hepatopatia e virgens para a terapia do VHC, foram tratados com Interferon Peguilado Alfa 2a de 40 KDa associado a Ribavirina por 48 semanas. Coletamos 20 amostras - horas 0, 4, 8, 12, 18, 24, 30, 36, 42, 48, dias 3, 4,7, 8, 15, 22, 29, 43, 57 e semana 12 - para quantificação do HCV (TaqMan®) e do HIV após o início da terapia. Os dados basais evidenciavam que o Genótipo 1 correspondia a 15 pacientes, enquanto o Genótipo 3 a 11. A mediana do VHC foi de 1.285.000 UI/ml, CD4 médio 573/mm3 e a média da carga viral do HIV 1109 cp/ml. Em uma análise por intenção de tratamento, o percentual obtido de resposta virológica sustentada (RVS) foi 26,9%. A única correlação estatisticamente significativa entre as variáveis analisadas e parâmetros cinéticos calculados, e a obtenção de RVS ocorreu entre RVS e Genótipo 3 (p < 0,04). Houve ajuste para os parâmetros cinéticos calculados para 18 pacientes. Pacientes com RVS apresentaram maiores taxas de eficiência do Interferon, eliminação de células infectadas e eliminação de vírions livres, assim como as Fases 1 e 2 foram mais rápidas entre eles. A ausência de redução do VHC de um log10 em 24 ou 48 horas, obteve um VPN de 100% para RVS. Ausência de queda de dois log10 nos dias oito e 29 obteve VPN de 92,31% e 100%, havendo associação entre a presença dessa resposta virológica precoce (RVP) e a obtenção de RVS (p=0,003 e p=0,01). A cinética viral mostra-se uma ferramenta útil no manejo clínico e predição muito precoce da ausência de RVS, o que é muito importante, particularmente para os co-infectados com o HIV, ante o complexo manuseio clínico dessa situação.
 
Title in English
HCV Viral knetics among HIV co-infected patients
Keywords in English
Hepatitis C
HIV
Interferon alpha-2a
Kinetics
Abstract in English
Twenty six co-infected patients were treated with PegIFN A2A and Ribavirin for 48 weeks. Twenty samples were drew at hours 0, 4, 8, 12, 18, 24, 30, 36, 42, 48, days 3, 4, 7, 8, 22, 29, 43, 57 and week 12 to HIV and HCV (TaqMan®) quantification after began medication. Basal data showed Genotype 1 in 15 patients, 3 in 11. Median HCV were 1.285.000 UI/ml, mean CD4 573/mm3 and mean HIV 1109 cp/ml. SVR was associated only with Genotype 3 (p<0,04). Overal SVR (ITT) were 26,9%. We obtained fitted viral kinetics parameters for 18 patients. Patients with SVR showed higher Interferon efficacy, infected cells clearance, free virion clearance and faster phase 1 and 2. Reduction on HCV load of less than one log10 at 24 or 48 hs had a NPV of 100% for SVR. Less than two log decay at days 8 and 29 had 92,31 and 100% of NPV and the presence of those reduction were associated with SVR p=0,003 and p=0,01). Viral kinetics are an important tool regarding clinic management and very early prediction of absence of SVR, wich is very important for the HIV co-infected patients for whom the clicical management is very complex.
 
WARNING - Viewing this document is conditioned on your acceptance of the following terms of use:
This document is only for private use for research and teaching activities. Reproduction for commercial use is forbidden. This rights cover the whole data about this document as well as its contents. Any uses or copies of this document in whole or in part must include the author's name.
TeseESAA2006.pdf (1.35 Mbytes)
Publishing Date
2006-04-10
 
WARNING: Learn what derived works are clicking here.
All rights of the thesis/dissertation are from the authors.
CeTI-SC/STI
© 2001-2024. Digital Library of Theses and Dissertations of USP.